Is Edwards Lifesciences (EW) Pricing Look Attractive After Recent Pullback?

2026-04-07 02:46:52

Abstract generation in progress

Edwards Lifesciences (EW) stock has seen a recent pullback, dropping 3.8% in the last week and 4.9% in the past month, although its 1-year return is 11.9%. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 11.6% at its current price of around US$79.34, with an estimated intrinsic value of $89.80 per share. However, its Price-to-Earnings (P/E) ratio of 43.47x is significantly higher than the Medical Equipment industry average of 27.73x and Simply Wall St’s Fair Ratio of 35.88x, indicating it might be overvalued based on earnings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.